跳至主要内容
临床试验/NCT07554040
NCT07554040尚未招募不适用

Amisulpride Used for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery: a Prospective Observational Cohort Study

Second Affiliated Hospital, School of Medicine, Zhejiang University0 个研究点目标入组 526 人开始时间: 2026年5月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
526
主要终点
Complete remission (CR) rate within 24 hours postoperatively

研究概览

简要总结

This study aims to focus on patients undergoing gynecological laparoscopic surgery and further evaluate the role of amisulpride in preventing postoperative nausea and vomiting in these patients.

详细描述

Gynecological laparoscopic surgery patients usually combine multiple high-risk factors such as being 'female,' undergoing 'laparoscopic procedures,' and having 'gynecological surgery,' making the prevention and treatment of PONV a key focus and challenge.Among patients undergoing gynecological laparoscopic surgery, there is still a lack of targeted clinical data support.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 1. 18<BMI≤30kg/m2
  • Patients scheduled to undergo gynecological laparoscopic surgery (e.g., ovary, fallopian tube, uterus, and gynecological tumors, etc., with an expected surgery duration of ≤3 hours)

排除标准

  • 1. ASA class IV or above
  • Long-term use of opioid drugs or non-steroidal anti-inflammatory drugs
  • Undergoing radiotherapy and chemotherapy 4.Allergic to the medication used 5.Pregnant or breastfeeding women 6.Previously existing vestibular disorders or chronic dizziness, easily nauseous 7.Recent use of antiemetic drugs or prophylactic antiemetic regimen (within 7 days before surgery) 8.Presence of neurological or psychiatric disorders, or cognitive impairment

研究组 & 干预措施

Amisulpride

Receiving amisulpride (5mg) as postoperative prophylactic antiemetic drugs

干预措施: Tropisetron (Drug)

Tropisetron

receiving tropisetron (2mg) as postoperative prophylactic antiemetic drugs

结局指标

主要结局

Complete remission (CR) rate within 24 hours postoperatively

时间窗: 1 day

The proportion of patients who, within 24 hours after surgery, experience neither vomiting episodes (vomiting/retching) nor require rescue antiemetic medication

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

相似试验

Amisulpride for the Prevention of Postoperative... | 临床试验